Bio

Associate Director of Biology, Arvinas

Ph.D., Biochemistry, Dartmouth College

B.S., Nutritional Sciences, Cornell University

Dr. Chris Hickey has over 20 years of experience in research, previously in academia and currently working in the pharmaceutical industry. Dr. Hickey is an expert in protein biochemistry, cellular protein homeostasis, and the therapeutic strategy called targeted protein degradation—the use of pharmaceuticals to destroy proteins that drive diseases. He has held positions of increasing responsibility aimed at developing treatments for cancers, inflammatory disorders, and neurological diseases. Dr. Hickey manages a group of several scientists as well as external vendors in directing pre-clinical drug development.

Dr. Hickey has trained many scientists and students, including several interns, both in industry and academia. During his time in academia, Dr. Hickey taught courses in biochemistry, cell biology, anatomy and physiology, and nutrition.

Dr. Hickey has published over 15 research articles in journals such as Nature Structural & Molecular Biology, PNAS, EMBO Journal, Molecular Biology of the Cell, Journal of Biological Chemistry, and Genetics. He also published a highly cited review on the SUMO pathway in Nature Reviews Molecular and Cellular Biology and co-edited a book on Targeted Protein Degradation that was published in Methods in Molecular Biology in 2021. Dr. Hickey has been a peer reviewer for several journals throughout his career.